Crinetics Pharmaceuticals Inc. (6Z4)
Market Closed
17 Jul, 20:00
XSTU 
€
73. 24
-0.06
-0.0819%
€
- Market Cap
- P/E Ratio
- Div Yield
260 Volume
-3.64 Eps
€ 73.3
Previous Close Want to track 6Z4 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
6Z4 Earnings Reports FAQ
What is the earnings per share (EPS) for 6Z4?
The current EPS is -3.64.
What is the company's earnings growth rate?
Crinetics Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Crinetics Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Crinetics Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 6Z4 at this time, as Crinetics Pharmaceuticals Inc has no recent EPS data to calculate it.
